Market Research Industry Reports

CJ HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The companys portfolio includes biologicals, antibiotics, anti cancer, parenteral nutrition, total parenteral nutrition products. It offers APIs such as cefozopran, cefmenoxime and cefotiam. It provides OTC drugs such as CJ condition, hongsamjin gold, hutgaesoo, mach max, roboca poli, sankle eye drops, and solar vita. The company conducts research and development of new drugs for treatment of digestive, cancers, gastrointestinal conditions, inflammatory diseases. The company has production facilities in Osong and Daeso, Korea. It has operations in China, Germany, Japan, South Korea and Vietnam. CJ HealthCare is headquartered in Seoul, South Korea.

CJ HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
YL Biologics Enters into Licensing Agreement with CJ HealthCare 10
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 11
Acquisition 12
CJ CheilJedang Plans to Divest CJ HealthCare for USD1.17 Billion 12
CJ HealthCare Corp - Key Competitors 13
CJ HealthCare Corp - Key Employees 14
CJ HealthCare Corp - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables

List of Tables
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Key Facts 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
YL Biologics Enters into Licensing Agreement with CJ HealthCare 10
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 11
CJ CheilJedang Plans to Divest CJ HealthCare for USD1.17 Billion 12
CJ HealthCare Corp, Key Competitors 13
CJ HealthCare Corp, Key Employees 14
CJ HealthCare Corp, Other Locations 15
CJ HealthCare Corp, Subsidiaries 15

List Of Figures

List of Figures
Unisys Corporation, Performance Chart (2013 - 2017) 34
Unisys Corporation, Ratio Charts 44

CJ HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The companys portfolio includes biologicals, antibiotics, anti cancer,

USD 250View Report

Crossject SA (ALCJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free

USD 250View Report

Hartford HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hartford HealthCare Corp (HHC) is a healthcare organization that offers clinical care, education and research services. The organizations services include behavioral and mental health, bone and joint care, cancer, cardiology

USD 250View Report

Fisher & Paykel Healthcare Corporation Limited (FPH) - Product Pipeline Analysis, 2017 Update

Fisher & Paykel Healthcare Corporation Limited (Fisher & Paykel) designs, manufactures and markets products and systems for use in acute care, respiratory care, and obstructive sleep apnea. The company offers

USD 750View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :16
Country :South Korea
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube